MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

ONO-8430506

CAS No. : 1354805-08-5

MCE 站：ONO-8430506

产品活性：ONO-8430506 是一种有效的，具有口服活性的 autotaxin (ATX)/ENPP2 抑制剂，抑制小鼠血浆中 ATX 活性，IC₉₀ 为 100 nM。

研究领域：Metabolic Enzyme/Protease

作用靶点：Phosphodiesterase (PDE)

In Vitro: Autotaxin, also known as ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2), is a secreted enzyme that has lysophospholipase D activity. The IC₅₀s of ONO-8430506 for the lysophospholipase D (LysoPLD) activity of recombinant human ATX/ENPP2 are 5.1 nM in an assay using synthetic fluorescent substrate (FS-3) ａnd 4.5 nM in an assay using a natural substrate (16:0-LPC).
ONO-8430506 shows efficient inhibition of lysophosphatidic acid (LPA) formation, with IC₅₀s of approximately 10 nM with both recombinant ａnd plasma derived ATX/ENPP2 from various animal species.

In Vivo: ONO-8430506 (10 mg/kg/day; gavage; for 21 days) slows initial tumor growth ａnd limits lung metastasis.
ONO-8430506 decreases the initial phase of breast tumor growth ａnd subsequent lung metastases by ~60% in a syngeneic orthotopic mouse model.
ONO-8430506 (oral; 30 mg/kg) demonstrates good pharmacokinetics ａnd persistently inhibits plasma lysophosphatidic acid formation in rats.
ONO-8430506 (30 or 100 mg/kg) enhances the antitumor effect of Paclitaxel in a breast cancer model.
ONO-8430506 exhibits moderate oral bioavailability (rat 51.6%, dog 71.1%, ａnd monkey 30.8%) ａnd C_max (rat 261, dog 1670, ａnd monkey 63 ng/mL) following oral administration (rat 1, dog 1, ａnd monkey 1 mg/kg).
ONO-8430506 exhibits terminal elimination half-lives (rat 3.4, dog 8.9, ａnd monkey 7.9 h) due to low plasma clearance (8.2, 4.7, ａnd 5.8 mL/min/kg respectively) combined with large volumes of distribution (1474, 1863, ａnd 2275 mL/kg respectively) following intravenous administration (rat 0.3, dog 0.3, ａnd monkey 0.3 mg/kg).

相关产品：IBMX  |  Bucladesine sodium  |  Rolipram  |  Sildenafil  |  Apremilast  |  Ziritaxestat  |  Dipyridamole  |  Roflumilast  |  Theophylline  |  Icariin  |  Milri  |  PF-04957325  |  Tadalafil  |  Cilostamide  |  ITI-214  |  EHNA hydrochloride  |  Cilostazol  |  Zatolmilast  |  Crisaborole  |  Ibudilast  |  Pentoxifylline  |  Mardepodect  |  W-7 hydrochloride  |  Cilomilast  |  Bay 60-7550  |  BRL-50481  |  PF-8380  |  Vardenafil hydrochloride

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。